[SCHEDULE 13G/A] OmniAb, Inc. SEC Filing
Schedule 13G/A filed for OmniAb, Inc. (OABI) discloses that several related entities and individuals report beneficial ownership of the issuer's common stock. Ash X LP and RLG GP each report ownership of 8,271,347 shares, representing approximately 5.8% of the outstanding common stock. RLG Capco II LLC holds 1,800,246 shares (about 1.3%) and Joel Greenblatt holds 1,428,571 shares (about 1.0%). Robert Goldstein is reported as beneficial owner of 10,071,593 shares (about 7.0%), reflecting combined holdings through entities he controls. The percentages are calculated using 122,701,294 shares outstanding as of July 30, 2025 plus 21,254,106 additional shares issued on August 25, 2025. The filing states the holdings are not intended to influence control of the issuer.
Schedule 13G/A depositato per OmniAb, Inc. (OABI) indica che diverse entità correlate e persone fisiche dichiarano la proprietà beneficiaria delle azioni ordinarie dell'emittente. Ash X LP e RLG GP possiedono ciascuna 8.271.347 azioni, pari a circa 5,8% del capitale sociale in circolazione. RLG Capco II LLC detiene 1.800.246 azioni (circa 1,3%) e Joel Greenblatt possiede 1.428.571 azioni (circa 1,0%). Robert Goldstein è indicato come proprietario beneficiario di 10.071.593 azioni (circa 7,0%), riflettendo partecipazioni complessive tramite entità da lui controllate. Le percentuali sono calcolate su 122.701.294 azioni in circolazione al 30 luglio 2025 più 21.254.106 azioni emesse il 25 agosto 2025. Il documento precisa che tali partecipazioni non mirano a influenzare il controllo dell'emittente.
Schedule 13G/A presentado para OmniAb, Inc. (OABI) revela que varias entidades relacionadas y personas físicas informan la propiedad beneficiaria de las acciones ordinarias de la emisora. Ash X LP y RLG GP poseen cada una 8.271.347 acciones, lo que supone aproximadamente el 5,8% del capital social en circulación. RLG Capco II LLC tiene 1.800.246 acciones (aprox. 1,3%) y Joel Greenblatt posee 1.428.571 acciones (aprox. 1,0%). Robert Goldstein figura como propietario beneficiario de 10.071.593 acciones (aprox. 7,0%), reflejando participaciones combinadas a través de entidades que controla. Los porcentajes se calculan sobre 122.701.294 acciones en circulación al 30 de julio de 2025 más 21.254.106 acciones adicionales emitidas el 25 de agosto de 2025. El informe indica que estas tenencias no tienen la intención de influir en el control de la emisora.
OmniAb, Inc. (OABI)에 대해 제출된 Schedule 13G/A에는 여러 관련 법인 및 개인이 발행회사의 보통주에 대한 실질적 소유권을 보고하고 있다고 기재되어 있습니다. Ash X LP와 RLG GP는 각각 8,271,347주를 보유하고 있어 전체 발행주식의 약 5.8%에 해당합니다. RLG Capco II LLC는 1,800,246주(약 1.3%)를 보유하고 있으며 Joel Greenblatt는 1,428,571주(약 1.0%)를 보유하고 있습니다. Robert Goldstein는 그가 지배하는 법인을 통한 보유를 합산하여 10,071,593주(약 7.0%)의 실질적 소유자로 보고되었습니다. 비율은 2025년 7월 30일 기준 발행주식 122,701,294주에 2025년 8월 25일 추가로 발행된 21,254,106주를 더해 계산되었습니다. 보고서에는 이러한 보유가 발행회사의 지배권 행사를 목적으로 하지 않는다고 명시되어 있습니다.
Schedule 13G/A déposé pour OmniAb, Inc. (OABI) indique que plusieurs entités liées et des personnes physiques déclarent détenir la propriété bénéficiaire des actions ordinaires de l'émetteur. Ash X LP et RLG GP détiennent chacune 8 271 347 actions, soit environ 5,8% du capital social en circulation. RLG Capco II LLC détient 1 800 246 actions (environ 1,3%) et Joel Greenblatt possède 1 428 571 actions (environ 1,0%). Robert Goldstein est déclaré propriétaire bénéficiaire de 10 071 593 actions (environ 7,0%), reflétant des participations combinées via des entités qu'il contrôle. Les pourcentages sont calculés à partir de 122 701 294 actions en circulation au 30 juillet 2025, plus 21 254 106 actions supplémentaires émises le 25 août 2025. le dépôt précise que ces participations n'ont pas pour but d'influencer le contrôle de l'émetteur.
Für OmniAb, Inc. (OABI) eingereichte Schedule 13G/A legt offen, dass mehrere verbundene Gesellschaften und Einzelpersonen wirtschaftliches Eigentum an den Stammaktien des Emittenten melden. Ash X LP und RLG GP halten jeweils 8.271.347 Aktien, was etwa 5,8% des ausstehenden Stammkapitals entspricht. RLG Capco II LLC besitzt 1.800.246 Aktien (etwa 1,3%) und Joel Greenblatt hält 1.428.571 Aktien (etwa 1,0%). Robert Goldstein wird als wirtschaftlicher Eigentümer von 10.071.593 Aktien (etwa 7,0%) angegeben, was die kumulierten Beteiligungen über von ihm kontrollierte Einheiten widerspiegelt. Die Prozentsätze basieren auf 122.701.294 ausstehenden Aktien zum 30. Juli 2025 zuzüglich 21.254.106 zusätzlicher Aktien, die am 25. August 2025 ausgegeben wurden. Die Einreichung stellt klar, dass die Beteiligungen nicht darauf abzielen, die Kontrolle über den Emittenten zu beeinflussen.
- Clear disclosure of beneficial ownership percentages for each reporting person, meeting SEC reporting requirements
- Identification of control relationships (e.g., RLG GP as General Partner of Ash X, managerial roles) that clarify how holdings are connected
- Largest individual stake disclosed: Robert Goldstein reported beneficial ownership of 10,071,593 shares (~7.0%)
- None.
Insights
TL;DR: Insider-related entities hold meaningful stakes, with Goldstein at ~7%, a disclosure that can affect float and voting dynamics.
The filing provides clear, itemized beneficial ownership figures for related entities and principals. Robert Goldstein's aggregate beneficial ownership of 10,071,593 shares (~7.0%) is the largest single disclosed stake and crosses the common 5% reporting threshold, which requires transparency and can influence perceptions of shareholder alignment and potential voting outcomes. Ash X LP and RLG GP each report identical holdings of 8,271,347 shares (~5.8%), reflecting their related-party structure. All reported positions indicate sole voting and dispositive power with no shared power disclosed. This is primarily a disclosure event rather than an operational update.
TL;DR: Related-party ownership and single-person signatures merit attention for governance transparency and potential coordination.
The Schedule 13G/A shows multiple reporting persons tied by common management and control, with signatures by Robert Goldstein and Joel Greenblatt. The filing clarifies roles (general partner, manager) and confirms sole voting/dispositive power for reported shares, which simplifies accountability but underscores concentrated influence among affiliated parties. The certification affirms the holdings are not for control purposes. Investors and governance committees should note the concentration of economic and voting power in affiliated entities when assessing director elections or contested matters.
Schedule 13G/A depositato per OmniAb, Inc. (OABI) indica che diverse entità correlate e persone fisiche dichiarano la proprietà beneficiaria delle azioni ordinarie dell'emittente. Ash X LP e RLG GP possiedono ciascuna 8.271.347 azioni, pari a circa 5,8% del capitale sociale in circolazione. RLG Capco II LLC detiene 1.800.246 azioni (circa 1,3%) e Joel Greenblatt possiede 1.428.571 azioni (circa 1,0%). Robert Goldstein è indicato come proprietario beneficiario di 10.071.593 azioni (circa 7,0%), riflettendo partecipazioni complessive tramite entità da lui controllate. Le percentuali sono calcolate su 122.701.294 azioni in circolazione al 30 luglio 2025 più 21.254.106 azioni emesse il 25 agosto 2025. Il documento precisa che tali partecipazioni non mirano a influenzare il controllo dell'emittente.
Schedule 13G/A presentado para OmniAb, Inc. (OABI) revela que varias entidades relacionadas y personas físicas informan la propiedad beneficiaria de las acciones ordinarias de la emisora. Ash X LP y RLG GP poseen cada una 8.271.347 acciones, lo que supone aproximadamente el 5,8% del capital social en circulación. RLG Capco II LLC tiene 1.800.246 acciones (aprox. 1,3%) y Joel Greenblatt posee 1.428.571 acciones (aprox. 1,0%). Robert Goldstein figura como propietario beneficiario de 10.071.593 acciones (aprox. 7,0%), reflejando participaciones combinadas a través de entidades que controla. Los porcentajes se calculan sobre 122.701.294 acciones en circulación al 30 de julio de 2025 más 21.254.106 acciones adicionales emitidas el 25 de agosto de 2025. El informe indica que estas tenencias no tienen la intención de influir en el control de la emisora.
OmniAb, Inc. (OABI)에 대해 제출된 Schedule 13G/A에는 여러 관련 법인 및 개인이 발행회사의 보통주에 대한 실질적 소유권을 보고하고 있다고 기재되어 있습니다. Ash X LP와 RLG GP는 각각 8,271,347주를 보유하고 있어 전체 발행주식의 약 5.8%에 해당합니다. RLG Capco II LLC는 1,800,246주(약 1.3%)를 보유하고 있으며 Joel Greenblatt는 1,428,571주(약 1.0%)를 보유하고 있습니다. Robert Goldstein는 그가 지배하는 법인을 통한 보유를 합산하여 10,071,593주(약 7.0%)의 실질적 소유자로 보고되었습니다. 비율은 2025년 7월 30일 기준 발행주식 122,701,294주에 2025년 8월 25일 추가로 발행된 21,254,106주를 더해 계산되었습니다. 보고서에는 이러한 보유가 발행회사의 지배권 행사를 목적으로 하지 않는다고 명시되어 있습니다.
Schedule 13G/A déposé pour OmniAb, Inc. (OABI) indique que plusieurs entités liées et des personnes physiques déclarent détenir la propriété bénéficiaire des actions ordinaires de l'émetteur. Ash X LP et RLG GP détiennent chacune 8 271 347 actions, soit environ 5,8% du capital social en circulation. RLG Capco II LLC détient 1 800 246 actions (environ 1,3%) et Joel Greenblatt possède 1 428 571 actions (environ 1,0%). Robert Goldstein est déclaré propriétaire bénéficiaire de 10 071 593 actions (environ 7,0%), reflétant des participations combinées via des entités qu'il contrôle. Les pourcentages sont calculés à partir de 122 701 294 actions en circulation au 30 juillet 2025, plus 21 254 106 actions supplémentaires émises le 25 août 2025. le dépôt précise que ces participations n'ont pas pour but d'influencer le contrôle de l'émetteur.
Für OmniAb, Inc. (OABI) eingereichte Schedule 13G/A legt offen, dass mehrere verbundene Gesellschaften und Einzelpersonen wirtschaftliches Eigentum an den Stammaktien des Emittenten melden. Ash X LP und RLG GP halten jeweils 8.271.347 Aktien, was etwa 5,8% des ausstehenden Stammkapitals entspricht. RLG Capco II LLC besitzt 1.800.246 Aktien (etwa 1,3%) und Joel Greenblatt hält 1.428.571 Aktien (etwa 1,0%). Robert Goldstein wird als wirtschaftlicher Eigentümer von 10.071.593 Aktien (etwa 7,0%) angegeben, was die kumulierten Beteiligungen über von ihm kontrollierte Einheiten widerspiegelt. Die Prozentsätze basieren auf 122.701.294 ausstehenden Aktien zum 30. Juli 2025 zuzüglich 21.254.106 zusätzlicher Aktien, die am 25. August 2025 ausgegeben wurden. Die Einreichung stellt klar, dass die Beteiligungen nicht darauf abzielen, die Kontrolle über den Emittenten zu beeinflussen.